Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 1996

View Archived Issues

RPR continues research into taxanes

Antitumor enhancers claimed by Taiho

Japanese researchers disclose substance P antagonists

Phase IIa trial on Isis antiinflammatory antisense compound completed

Patent issued for Vical's core technology

New company formed with focus on women's health

E-Z-EM introduces new dysphagia diagnostic kit

Incyte and Abbott expand genomic database agreement

Priority review for Crinone

Sterinetics System successfully inactivates multiple viruses in IVIg

RTP to accelerate development of insoluble drug delivery technology

Houghten's lead CRA safe in diabetics

New patient-activated drug delivery system from Medtronic released in Europe

Moisture-managing foam wound dressing introduced

GenPharm generates human anti-IL-8 antibodies

Phase II trials begin on low-dose interferon alfa for Sjogren's syndrome

Shareholder meeting set to approve Bio-Dental-Zila merger

Cytel announces plans for Cylexin at investors conference

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...